AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-86 |
Results: 76-86/86
ON THE MECHANISM OF COAGULATION INHIBITION ON SURFACES WITH END-POINTIMMOBILIZED HEPARIN
Authors: ELGUE G BLOMBACK M OLSSON P RIESENFELD J
Citation: G. Elgue et al., ON THE MECHANISM OF COAGULATION INHIBITION ON SURFACES WITH END-POINTIMMOBILIZED HEPARIN, Thrombosis and haemostasis, 70(2), 1993, pp. 289-293
ENDOGENOUS ESTRADIOL DOES NOT INDUCE HYPERCOAGULATION
Authors: BREMME K WRAMSBY H ANDERSSON O WALLIN M BLOMBACK M
Citation: K. Bremme et al., ENDOGENOUS ESTRADIOL DOES NOT INDUCE HYPERCOAGULATION, Thrombosis and haemostasis, 69(6), 1993, pp. 716-716
DOSAGE OF LOW-MOLECULAR-WEIGHT HEPARIN IN RISK PREGNANCIES USING PRE-THROMBOTIC MARKERS
Authors: BREMME K BLOMBACK M
Citation: K. Bremme et M. Blomback, DOSAGE OF LOW-MOLECULAR-WEIGHT HEPARIN IN RISK PREGNANCIES USING PRE-THROMBOTIC MARKERS, Thrombosis and haemostasis, 69(6), 1993, pp. 717-717
SOLUBLE FIBRIN - A PREDICTOR OF DEVELOPMENT AND OUTCOME OF MULTIPLE ORGAN FAILURE
Authors: BREDBACKA S BLOMBACK M WIMAN B
Citation: S. Bredbacka et al., SOLUBLE FIBRIN - A PREDICTOR OF DEVELOPMENT AND OUTCOME OF MULTIPLE ORGAN FAILURE, Thrombosis and haemostasis, 69(6), 1993, pp. 728-728
ANTITHROMBIN CONCENTRATE DOSE TO PATIENTS WITH ACQUIRED ANTITHROMBIN DEFICIENCY
Authors: ALBERT J BLOMBACK M
Citation: J. Albert et M. Blomback, ANTITHROMBIN CONCENTRATE DOSE TO PATIENTS WITH ACQUIRED ANTITHROMBIN DEFICIENCY, Thrombosis and haemostasis, 69(6), 1993, pp. 790-790
HALF CITRATE, 0.5 CPD, AS ANTICOAGULANT GIVES BETTER STABILITY OF COAGULATION FACTOR-VIII WITHOUT ACTIVATION OF HEMOSTASIS
Authors: SUONTAKA AM AKERBLOM O BLOMBACK M HOGMAN C ERIKSSON L
Citation: Am. Suontaka et al., HALF CITRATE, 0.5 CPD, AS ANTICOAGULANT GIVES BETTER STABILITY OF COAGULATION FACTOR-VIII WITHOUT ACTIVATION OF HEMOSTASIS, Thrombosis and haemostasis, 69(6), 1993, pp. 809-809
COMPARISON OF COMMERCIAL KITS FOR LUPUS ANTICOAGULANT DETERMINATION
Authors: BOKAREWA M EGBERG N BLOMBACK M ARFORS L
Citation: M. Bokarewa et al., COMPARISON OF COMMERCIAL KITS FOR LUPUS ANTICOAGULANT DETERMINATION, Thrombosis and haemostasis, 69(6), 1993, pp. 1031-1031
MUTATIONS OF THE VON-WILLEBRAND-FACTOR GENE IN THE PATIENTS WITH VON-WILLEBRANDS DISEASE IN THE ALAND ISLAND
Authors: BLOMBACK M ZHANG ZP NYMAN D ANVRET M
Citation: M. Blomback et al., MUTATIONS OF THE VON-WILLEBRAND-FACTOR GENE IN THE PATIENTS WITH VON-WILLEBRANDS DISEASE IN THE ALAND ISLAND, Thrombosis and haemostasis, 69(6), 1993, pp. 1178-1178
MUTATION SCREENING OF THE VON-WILLEBRAND-FACTOR GENE IN VON-WILLEBRAND DISEASE TYPE-I AND TYPE-III PATIENTS
Authors: ZHANG ZP FALK G EGBERG N BLOMBACK M ANVRET M
Citation: Zp. Zhang et al., MUTATION SCREENING OF THE VON-WILLEBRAND-FACTOR GENE IN VON-WILLEBRAND DISEASE TYPE-I AND TYPE-III PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 1179-1179
PREVENTION OF POSTSURGICAL BLEEDING IN ORAL-SURGERY USING TRANEXAMIC ACID WITHOUT DOSE MODIFICATION OF ORAL ANTICOAGULANTS
Authors: RAMSTROM G SINDETPEDERSEN S HALL G BLOMBACK M ALANDER U
Citation: G. Ramstrom et al., PREVENTION OF POSTSURGICAL BLEEDING IN ORAL-SURGERY USING TRANEXAMIC ACID WITHOUT DOSE MODIFICATION OF ORAL ANTICOAGULANTS, Journal of oral and maxillofacial surgery, 51(11), 1993, pp. 1211-1216
MUTATIONS OF VON-WILLEBRAND-FACTOR GENE IN FAMILIES WITH VON-WILLEBRAND DISEASE IN THE ALAND-ISLANDS
Authors: ZHANG ZP BLOMBACK M NYMAN D ANVRET M
Citation: Zp. Zhang et al., MUTATIONS OF VON-WILLEBRAND-FACTOR GENE IN FAMILIES WITH VON-WILLEBRAND DISEASE IN THE ALAND-ISLANDS, Proceedings of the National Academy of Sciences of the United Statesof America, 90(17), 1993, pp. 7937-7940
Risultati: 1-25 | 26-50 | 51-75 | 76-86 |